Table 1 Patients baseline data

No. patients

 n

272,230

322,407

353,818

405,495

443,943

475,418

506,221

532,394

557,679

565,262

574,249

580,222

Age

 0–30

  n

603

619

684

893

1072

1189

1298

1473

1589

1594

1665

1678

  %

0.2

0.2

0.2

0.2

0.2

0.3

0.3

0.3

0.3

0.3

0.3

0.3

 31–40

  n

3488

4086

4519

5140

5698

6165

6496

6828

7195

7221

7602

7846

  %

1.3

1.3

1.3

1.3

1.3

1.3

1.3

1.3

1.3

1.3

1.3

1.4

 41–50

  n

15,658

18,902

20,723

23,847

26,157

28,523

30,524

32,418

33,870

33,973

33,838

33,875

  %

5.8

5.9

5.9

5.9

5.9

6.0

6.0

6.1

6.1

6.0

5.9

5.8

 51–60

  n

44,330

53,046

59,448

68,438

73,860

77,242

80,621

83,833

86,929

87,328

89,379

91,179

  %

16.3

16.5

16.8

16.9

16.6

16.2

15.9

15.7

15.6

15.4

15.6

15.7

 61–70

  n

94,715

108,701

114,317

126,291

134,234

138,947

142,553

143,662

146,125

147,232

148,731

149,458

  %

34.8

33.7

32.3

31.1

30.2

29.2

28.2

27.0

26.2

26.0

25.9

25.8

 71–80

  n

81,740

97,102

108,561

126,700

141,195

154,850

169,104

181,978

192,709

194,937

196,654

195,301

  %

30.0

30.1

30.7

31.2

31.8

32.6

33.4

34.2

34.6

34.5

34.2

33.7

 80+

  n

31,696

39,951

45,566

54,186

61,727

68,502

75,625

82,202

89,262

92,977

96,380

100,885

  %

11.6

12.4

12.9

13.4

13.9

14.4

14.9

15.4

16.0

16.4

16.8

17.4

Female gender

 n

106,443

139,086

162,025

193,781

220,973

241,668

257,076

270,660

283,446

286,676

290,607

292,302

 %

51.5

51.3

51.2

51.1

50.9

50.9

50.8

50.9

50.8

50.7

50.6

50.4

Smoker

 n

24,544

27,147

29,236

33,277

39,754

44,172

48,549

53,115

57,421

59,631

62,545

64,959

 %

9.0

8.4

8.3

8.2

9.0

9.3

9.6

10.0

10.3

10.5

10.9

11.2

BMI

 0–18.5

  n

446

176

149

147

1532

1794

1845

1935

2029

2080

2208

2178

  %

0.6

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

 18.5–24.9

  n

9782

5202

4848

4794

52,452

58,783

61,942

64,878

67,348

68,076

68,603

69,645

  %

13.7

12.5

12.3

12.7

12.5

12.5

12.3

12.2

12.1

12.1

12.0

12.0

 25.0–29.9

  n

28,650

16,202

15,056

14,162

160,124

178,845

189,735

198,157

206,727

208,359

210,000

210,317

  %

40.0

39.1

38.2

37.5

38.3

38.0

37.7

37.4

37.2

37.0

36.7

36.3

 30.0–34.9

  n

20,872

12,312

11,726

11,008

125,014

140,792

150,947

159,081

166,511

168,794

171,675

173,238

  %

29.1

29.7

29.7

29.2

29.9

29.9

30.0

30.0

30.0

29.9

30.0

29.9

 35.0–39.9

  n

8101

5033

4991

4903

52,728

60,226

65,537

70,023

74,078

75,821

77,638

79,152

  %

11.3

12.1

12.7

13.0

12.6

12.8

13.0

13.2

13.3

13.5

13.6

13.7

 40+

  n

3805

2557

2677

2728

26,168

30,646

33,898

36,464

39,052

40,550

42,669

44,260

HbA1c >8.5%

 n

22,821

28,588

30,563

36,343

36,264

42,762

47,335

49,624

52,187

50,426

47,825

47,951

%

8.4

8.9

8.6

9.0

8.2

9.0

9.4

9.3

9.4

8.9

8.3

8.3

Patient education

 n

34,840

73,454

89,348

106,870

125,175

137,569

147,672

156,205

162,850

165,923

168,197

169,877

 %

12.8

22.8

25.3

26.4

28.2

28.9

29.2

29.3

29.2

29.4

29.3

29.3